BR9610475A - Preparação de hemoglobinas de grau farmacêutico por tratamento térmico em forma parcialmente oxigenada - Google Patents
Preparação de hemoglobinas de grau farmacêutico por tratamento térmico em forma parcialmente oxigenadaInfo
- Publication number
- BR9610475A BR9610475A BR9610475A BR9610475A BR9610475A BR 9610475 A BR9610475 A BR 9610475A BR 9610475 A BR9610475 A BR 9610475A BR 9610475 A BR9610475 A BR 9610475A BR 9610475 A BR9610475 A BR 9610475A
- Authority
- BR
- Brazil
- Prior art keywords
- hemoglobins
- preparation
- heat treatment
- pharmaceutical grade
- partially oxygenated
- Prior art date
Links
- INGWEZCOABYORO-UHFFFAOYSA-N 2-(furan-2-yl)-7-methyl-1h-1,8-naphthyridin-4-one Chemical compound N=1C2=NC(C)=CC=C2C(O)=CC=1C1=CC=CO1 INGWEZCOABYORO-UHFFFAOYSA-N 0.000 title 1
- 102000001554 Hemoglobins Human genes 0.000 title 1
- 108010054147 Hemoglobins Proteins 0.000 title 1
- 238000010438 heat treatment Methods 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/795—Porphyrin- or corrin-ring-containing peptides
- C07K14/805—Haemoglobins; Myoglobins
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/14—Extraction; Separation; Purification
- C07K1/30—Extraction; Separation; Purification by precipitation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Hematology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/532,293 US5741894A (en) | 1995-09-22 | 1995-09-22 | Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
PCT/US1996/013511 WO1997010831A1 (en) | 1995-09-22 | 1996-08-20 | Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9610475A true BR9610475A (pt) | 1999-05-11 |
Family
ID=24121176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9610475A BR9610475A (pt) | 1995-09-22 | 1996-08-20 | Preparação de hemoglobinas de grau farmacêutico por tratamento térmico em forma parcialmente oxigenada |
Country Status (13)
Country | Link |
---|---|
US (1) | US5741894A (pt) |
EP (1) | EP0854725B1 (pt) |
JP (1) | JP2000500736A (pt) |
KR (1) | KR19990063654A (pt) |
CN (1) | CN1197392A (pt) |
AU (1) | AU716742B2 (pt) |
BR (1) | BR9610475A (pt) |
CA (1) | CA2229845A1 (pt) |
DE (1) | DE69625605T2 (pt) |
NO (1) | NO981270L (pt) |
TW (1) | TW360660B (pt) |
WO (1) | WO1997010831A1 (pt) |
ZA (1) | ZA967319B (pt) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6747132B2 (en) | 2000-11-29 | 2004-06-08 | Apex Biosciences, Inc. | Methods for the synthesis of a modified hemoglobin solution |
US7038016B2 (en) | 2001-08-21 | 2006-05-02 | Apex Bioscience, Inc. | Methods for purification of an activated PEG solution and for the synthesis of a modified hemoglobin solution |
US20110319332A1 (en) * | 2010-06-23 | 2011-12-29 | Bing Lou Wong | Treatment methods using a heat stable oxygen carrier-containing pharmaceutical composition |
US7932356B1 (en) | 2010-06-23 | 2011-04-26 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing pharmaceutical composition |
US8084581B1 (en) | 2011-04-29 | 2011-12-27 | Bing Lou Wong | Method for removing unmodified hemoglobin from cross-linked hemoglobin solutions including polymeric hemoglobin with a high temperature short time heat treatment apparatus |
US20130052232A1 (en) | 2011-08-31 | 2013-02-28 | Bing Lou Wong | Method for the preparation of a heat stable oxygen carrier-containing composition facilating beta-beta cross-linking |
JP7387597B2 (ja) | 2017-07-18 | 2023-11-28 | ヴァーテック・バイオ・インコーポレイテッド | ヘモグロビンを含む代用血液及び作製方法 |
KR20220082811A (ko) | 2019-08-29 | 2022-06-17 | 빌리언 킹 인터네셔널 리미티드 | 티오숙시닐-가교 헤모글로빈 유사체 및 이의 사용 및 제조 방법 |
WO2024081928A1 (en) * | 2022-10-14 | 2024-04-18 | Prolong Pharmaceuticals Llc | A stable hemoglobin protein composition |
Family Cites Families (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2248475C3 (de) * | 1972-10-03 | 1978-09-28 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Gewinnung von hepatitissicheren, lagerungsstabilen und infundierbaren Hämoglobinlösungen |
US3959128A (en) * | 1974-12-27 | 1976-05-25 | Preventive Systems, Inc | Process for removing endotoxin from biological fluids |
US4059512A (en) * | 1974-12-27 | 1977-11-22 | Preventive Systems, Inc. | Process for removing endotoxin from biological fluids |
US3991181A (en) * | 1975-06-18 | 1976-11-09 | Warner-Lambert Company | Injectable stroma free hemoglobin solution and its method of manufacture |
JPS56106559A (en) * | 1980-01-29 | 1981-08-24 | Riyoushiyoku Kenkyukai | Separation of globin |
US4623717A (en) * | 1980-03-05 | 1986-11-18 | Miles Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
EP0035204B2 (en) * | 1980-03-05 | 1991-05-22 | Miles Inc. | Pasteurized therapeutically active protein compositions |
US4440679A (en) * | 1980-03-05 | 1984-04-03 | Cutter Laboratories, Inc. | Pasteurized therapeutically active protein compositions |
US4291020A (en) * | 1980-05-16 | 1981-09-22 | The United States Of America As Represented By The Secretary Of Health & Human Services | Inactivation of non-A, non-B hepatitis agent |
DE3033932C2 (de) * | 1980-09-10 | 1984-05-24 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Kaltsterilisation von Blutgerinnungsfaktor VIII enthaltenden Präparaten |
JPS5754121A (en) * | 1980-09-19 | 1982-03-31 | Ajinomoto Co Inc | Production of substance having antiviral and carcinostatic activity |
US4314997A (en) * | 1980-10-06 | 1982-02-09 | Edward Shanbrom | Purification of plasma protein products |
US4381239A (en) * | 1981-02-10 | 1983-04-26 | Tanabe Seiyaku Co., Ltd. | Method for reducing the pyrogen content of or removing pyrogens from substances contaminated therewith |
US4465774A (en) * | 1981-07-16 | 1984-08-14 | Sherwood Medical Company | Standard or control material for glysocylated or total hemoglobin determination |
DE3130770C2 (de) * | 1981-08-04 | 1986-06-19 | Biotest-Serum-Institut Gmbh, 6000 Frankfurt | Verfahren zur Gewinnung von hepatitissicheren, sterilen, pyrogenfreien und stromafreien Hämoglobinlösungen |
US4456590B2 (en) * | 1981-11-02 | 1989-05-30 | Heat treatment of lyphilized blood clotting factor viii concentrate | |
US4438098A (en) * | 1982-01-27 | 1984-03-20 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Heat treatment of a non-A, non-B hepatitis agent to prepare a vaccine |
US4473494A (en) * | 1983-05-04 | 1984-09-25 | The United States Of America As Represented By The Secretary Of The Army | Preparation of stroma-free, non-heme protein-free hemoglobin |
US4529719A (en) * | 1983-05-04 | 1985-07-16 | Tye Ross W | Modified crosslinked stroma-free tetrameric hemoglobin |
FR2548670B1 (fr) * | 1983-07-07 | 1985-10-25 | Merieux Inst | Procede de preparation des principales proteines du sang hemolyse sous forme non denaturee |
US4540573A (en) * | 1983-07-14 | 1985-09-10 | New York Blood Center, Inc. | Undenatured virus-free biologically active protein derivatives |
US5281579A (en) * | 1984-03-23 | 1994-01-25 | Baxter International Inc. | Purified virus-free hemoglobin solutions and method for making same |
US4831012A (en) * | 1984-03-23 | 1989-05-16 | Baxter International Inc. | Purified hemoglobin solutions and method for making same |
DE3412144A1 (de) * | 1984-03-31 | 1985-10-10 | Biotest Pharma GmbH, 6000 Frankfurt | Verfahren zur herstellung hochgereinigter, stromafreier, hepatitissicherer human- und tierhaemoglobinloesungen |
EP0160260A3 (de) * | 1984-05-02 | 1986-10-08 | Bayer Ag | Verfahren zur Immobilisierung von biologischem Material |
US4598064A (en) * | 1984-06-27 | 1986-07-01 | University Of Iowa Research Foundation | Alpha-alpha cross-linked hemoglobins |
US4886755A (en) * | 1984-12-07 | 1989-12-12 | Bioprobe International, Inc. | Preparation of polymeric thiol gels for covalent bonding of biologically active ligands |
US4632980A (en) * | 1985-04-03 | 1986-12-30 | Immunologics | Ozone decontamination of blood and blood products |
CA1244349A (en) * | 1985-06-26 | 1988-11-08 | Jen-Chang Hsia | Purification of hemoglobin and modified hemoglobin by affinity chromatography |
US5194590A (en) * | 1986-06-20 | 1993-03-16 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
US5464814A (en) * | 1986-06-20 | 1995-11-07 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
US4826811A (en) * | 1986-06-20 | 1989-05-02 | Northfield Laboratories, Inc. | Acellular red blood cell substitute |
US4841023A (en) * | 1986-06-25 | 1989-06-20 | New York Blood Center, Inc. | Inactivation of viruses in labile protein-containing compositions using fatty acids |
ES2032802T5 (es) * | 1986-11-10 | 2004-01-16 | Biopure Corporation | Sucedaneo de sangre semisintetico extrapuro. |
US5084558A (en) * | 1987-10-13 | 1992-01-28 | Biopure Corporation | Extra pure semi-synthetic blood substitute |
CA1312009C (en) * | 1986-11-10 | 1992-12-29 | Carl W. Rausch | Extra pure semi-synthetic blood substitute |
GB8710598D0 (en) * | 1987-05-05 | 1987-06-10 | Star Medical Diagnostics Ltd | Hemoglobin based blood substitute |
US5189146A (en) * | 1987-05-05 | 1993-02-23 | Her Majesty The Queen In Right Of Canada, As Represented By The Minister Of National Defence | Pasteurizable, freeze-driable hemoglobin-based blood substitute |
US4808314A (en) * | 1987-09-18 | 1989-02-28 | Scripps Clinic And Research Foundation | Method for reducing bacterial endotoxin contamination in solutions of macromolecules |
US4909940A (en) * | 1987-12-30 | 1990-03-20 | New York Blood Center, Inc. | Extraction of process chemicals from labile biological mixtures with organic alcohols or with halogenated hydrocarbons |
US4861867A (en) * | 1988-02-03 | 1989-08-29 | Baxter International, Inc. | Purified hemoglobin solutions and method for making same |
DE3805459A1 (de) * | 1988-02-22 | 1989-08-31 | Biotest Pharma Gmbh | Verfahren zur sterilisation von blut, plasma, blut- und plasmaderivaten, zellsuspensionen oder dgl. |
JPH01238534A (ja) * | 1988-03-17 | 1989-09-22 | Mitsui Toatsu Chem Inc | エンドトキシンの除去方法 |
WO1989012456A1 (en) * | 1988-06-15 | 1989-12-28 | Baxter International Inc. | Method of purifying cross-linked hemoglobin |
CA1338244C (en) * | 1988-08-17 | 1996-04-09 | Xiang-Fu Wu | Purification of hemoglobin and methemoglobin by bioselective elution |
DE69027187T2 (de) * | 1989-06-15 | 1996-10-31 | Rorer Int Overseas | Verfahren zur inaktivierung von viren in mit viren verunreinigten pharmazeutischen zusammensetzungen |
US5386014A (en) * | 1989-11-22 | 1995-01-31 | Enzon, Inc. | Chemically modified hemoglobin as an effective, stable, non-immunogenic red blood cell substitute |
US5312808A (en) * | 1989-11-22 | 1994-05-17 | Enzon, Inc. | Fractionation of polyalkylene oxide-conjugated hemoglobin solutions |
US5234903A (en) * | 1989-11-22 | 1993-08-10 | Enzon, Inc. | Chemically modified hemoglobin as an effective, stable non-immunogenic red blood cell substitute |
WO1991009615A1 (en) * | 1989-12-29 | 1991-07-11 | Texas Tech University | Polyhemoglobin stabilized by purine derivatives and glutathione |
US5439882A (en) * | 1989-12-29 | 1995-08-08 | Texas Tech University Health Sciences Center | Blood substitute |
EP0517790A1 (en) * | 1990-02-27 | 1992-12-16 | The Board Of Regents, The University Of Texas System | Method for enhancing recovery of recombinant proteins |
JP2709419B2 (ja) * | 1990-08-06 | 1998-02-04 | バクスター、インターナショナル、インコーポレイテッド | 安定なヘモグロビンに基づく組成物及びその貯蔵方法 |
US5204451A (en) * | 1990-08-13 | 1993-04-20 | Baxter International Inc. | Activating hydroxyl groups of polymeric carriers using 4-fluorobenzenesulfonyl chloride for binding biologically active ligands |
JPH05502183A (ja) * | 1990-09-04 | 1993-04-22 | シャンブロム,エドワード | 血液、組織および生物体液の保存 |
US5922854A (en) * | 1991-06-14 | 1999-07-13 | Kumar; Ramesh | Purifying Human Hemogloblin from transgenic pig red cells and plasmids containing pig globin nucleic acids |
EP0590076A4 (en) * | 1991-06-14 | 1997-02-12 | Dnx Corp | Production of human hemoglobin in transgenic pigs |
CA2049275A1 (en) * | 1991-08-15 | 1993-02-16 | Paul Huntington | Purification of sf hemoglobin |
JP3331433B2 (ja) * | 1992-02-05 | 2002-10-07 | 財団法人生産開発科学研究所 | ヘモグロビン精製法 |
EP0655888A4 (en) * | 1992-06-12 | 1997-06-11 | Dnx Corp | PRODUCTION OF HUMAN HEMOGLOBIN IN TRANSGENIC PIGS. |
US5264555A (en) * | 1992-07-14 | 1993-11-23 | Enzon, Inc. | Process for hemoglobin extraction and purification |
JPH06105686A (ja) * | 1992-09-28 | 1994-04-19 | Toyobo Co Ltd | ポルフィリンモノクロ−ナル抗体構造遺伝子 |
US5407579A (en) * | 1993-07-02 | 1995-04-18 | National Science Council | Hemoglobin purification |
CA2106612C (en) * | 1993-09-21 | 2001-02-06 | Diana Pliura | Displacement chromatography process |
ZA951034B (en) * | 1993-09-21 | 1995-10-11 | Hemosol Inc | Displacements chromatography process and purified hemoglobin product |
US5456835A (en) * | 1993-11-08 | 1995-10-10 | Hemasure, Inc. | Device and process for removing free hemoglobin from blood |
US5665869A (en) * | 1993-11-15 | 1997-09-09 | Somatogen, Inc. | Method for the rapid removal of protoporphyrin from protoporphyrin IX-containing solutions of hemoglobin |
US5631219A (en) * | 1994-03-08 | 1997-05-20 | Somatogen, Inc. | Method of stimulating hematopoiesis with hemoglobin |
-
1995
- 1995-09-22 US US08/532,293 patent/US5741894A/en not_active Expired - Fee Related
-
1996
- 1996-08-20 DE DE69625605T patent/DE69625605T2/de not_active Expired - Fee Related
- 1996-08-20 JP JP9512701A patent/JP2000500736A/ja active Pending
- 1996-08-20 EP EP96928959A patent/EP0854725B1/en not_active Expired - Lifetime
- 1996-08-20 CA CA002229845A patent/CA2229845A1/en not_active Abandoned
- 1996-08-20 CN CN96197144A patent/CN1197392A/zh active Pending
- 1996-08-20 WO PCT/US1996/013511 patent/WO1997010831A1/en active IP Right Grant
- 1996-08-20 BR BR9610475A patent/BR9610475A/pt unknown
- 1996-08-20 KR KR1019980702107A patent/KR19990063654A/ko not_active Application Discontinuation
- 1996-08-20 AU AU68530/96A patent/AU716742B2/en not_active Ceased
- 1996-08-28 TW TW085110487A patent/TW360660B/zh active
- 1996-08-29 ZA ZA967319A patent/ZA967319B/xx unknown
-
1998
- 1998-03-20 NO NO981270A patent/NO981270L/no unknown
Also Published As
Publication number | Publication date |
---|---|
US5741894A (en) | 1998-04-21 |
JP2000500736A (ja) | 2000-01-25 |
EP0854725B1 (en) | 2003-01-02 |
KR19990063654A (ko) | 1999-07-26 |
NO981270D0 (no) | 1998-03-20 |
TW360660B (en) | 1999-06-11 |
WO1997010831A1 (en) | 1997-03-27 |
AU6853096A (en) | 1997-04-09 |
AU716742B2 (en) | 2000-03-02 |
MX9802059A (es) | 1998-08-30 |
DE69625605T2 (de) | 2003-10-16 |
NO981270L (no) | 1998-03-20 |
CA2229845A1 (en) | 1997-03-27 |
CN1197392A (zh) | 1998-10-28 |
ZA967319B (en) | 1997-03-04 |
DE69625605D1 (de) | 2003-02-06 |
EP0854725A1 (en) | 1998-07-29 |
EP0854725A4 (en) | 1999-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY2018020I2 (el) | Θεραπεια της νοσου ρομρε | |
NO20004133L (no) | Antistoffer mot human CD40 | |
CY2007001I2 (el) | Φαρμακευτικο σκευασμα για χρηση στη θεραπεια του διαβητη | |
GB0106183D0 (en) | Improvements in or relating to the treatment of lesions | |
BR9507944A (pt) | Composições alimenticias terapéuticas e métodos para diminuir flutuações de acucar no sangue | |
DE69630947D1 (de) | Mittel zur schmerzbehandlung | |
AU1705100A (en) | Blocking factor b to treat complement-mediated immune disease | |
EE04390B1 (et) | Paikne preparaat dermatoloogiliste seisundite raviks | |
BR9508115A (pt) | Composto composição farmacêutica e processos para tratar deficiências imunológicas ou controlar o aumento de câncer e para aumentar o número de linfócitos t citotóxicos em mamíferos | |
PT1181027E (pt) | Composicao dietetica ou farmaceutica para utilizacao na prevencao ou tratamento de hiperoxaluria | |
ID28441A (id) | Terapi untuk memperbaiki kesadaran | |
PL320916A1 (en) | Derivatives of piperasino 2,5-dione as modulators of drug-fastness in respect to amny drugs | |
BR9610475A (pt) | Preparação de hemoglobinas de grau farmacêutico por tratamento térmico em forma parcialmente oxigenada | |
ID27576A (id) | Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun | |
ZA984268B (en) | Method and composition for administering taxanes orally to human patients | |
GB9412844D0 (en) | Improvements in or relating to therapeutic methods | |
ID23447A (id) | Pengolahan untuk membuat derifat-derifat pirazol | |
EP1085892A4 (en) | VACCINE STRATEGY FOR THE PREVENTION AND TREATMENT OF CANCER | |
PT932400E (pt) | Derivados de anticonvulsionantes uteis no tratamento da dor neuropatica | |
EP1446167A4 (en) | TREATMENT OF DISEASES WITH PATCHES TO INCREASE HEALING AND TREATMENT OF PAIN | |
PT879054E (pt) | Aplicação de derivados de pirrolidina na preparação de medicamentos para o tratamento do abuso de drogas | |
AU2742395A (en) | Therapeutic or dietetic composition in the form of medicinal gel for the administration to pets | |
FI972637A0 (fi) | K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon | |
FI965171A0 (fi) | Oksatsofosforiinien, esimerkiksi ifosfamidin, enantiomeerien käyttö kasvainten hoidossa sivuvaikutuksien vähentämiseksi | |
KR960000327U (ko) | 무병장수하는 신선침제조방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EG | Technical examination (opinion): publication of technical examination (opinion) |